Research Article

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension

Table 3

Correlation between PVR and laboratory variables, liver function test, and therapies in POPH and IPAH.

POPHIPAH
rr

Liver function test
 Total bilirubin−0.3940.0310.2180.003
 Direct bilirubin−0.3640.0480.1780.018
 AST−0.1360.4740.1390.066
D-dimer0.0090.9640.0160.913
Blood cell counts
 WBC0.2750.1420.1790.117
 Neutrophils0.3940.0310.1070.167
NT-proBNP0.2030.2990.438<0.001
PCO20.0140.9400.0040.976
Target therapies−0.0760.6900.1330.076
MELD scores (per unit)−0.2430.195

Data were conducted via Pearson or Spearman correlation analyses. PVR, total bilirubin, direct bilirubin, AST, D-dimer, blood cell counts, NT-proBNP, and PCO2 were regarded as continuous variables. Target therapies and MELD scores were deemed as categorical variables. PVR, pulmonary vascular resistance; POPH, portopulmonary hypertension; IPAH, idiopathic pulmonary arterial hypertension; AST, aspartate aminotransferase; WBC, white blood cell; NT-proBNP, N-terminal pro brain natriuretic peptide; PCO2, partial pressure of carbon dioxide; MELD scores, model for end-stage liver disease scores; —, not applicable.